These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38898042)
1. Identification of 8 candidate microsatellite instability loci in colorectal cancer and validation of the ACVR2A mechanism in the tumor progression. Wang J; Zhang Z; Liu H; Liu N; Hu Y; Guo W; Li X Sci Rep; 2024 Jun; 14(1):14145. PubMed ID: 38898042 [TBL] [Abstract][Full Text] [Related]
2. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair. Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways. Hu Z; Long T; Ma Y; Zhu J; Gao L; Zhong Y; Wang X; Wang X; Li Z J Exp Clin Cancer Res; 2020 May; 39(1):76. PubMed ID: 32370786 [TBL] [Abstract][Full Text] [Related]
4. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer. Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687 [TBL] [Abstract][Full Text] [Related]
5. Leukotriene B4 receptor knockdown affects PI3K/AKT/mTOR signaling and apoptotic responses in colorectal cancer. Tang C; Wang A; Zhao Y; Mou W; Jiang J; Kuang J; Sun B; Tang E Biomol Biomed; 2024 Jan; 24(4):968-981. PubMed ID: 38259082 [TBL] [Abstract][Full Text] [Related]
6. Investigation of ENO2 as a promising novel marker for the progression of colorectal cancer with microsatellite instability-high. Cai J; Yang Y; Zhang L; Fang Y; Zhang Y; Tan M; Zhang J; Tang C; Ren H; Wang L; Xiang G; Xu F; Lan L; Li L; Zheng X BMC Cancer; 2024 May; 24(1):573. PubMed ID: 38724951 [TBL] [Abstract][Full Text] [Related]
7. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway. Yin F; Huang X; Xuan Y Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817 [TBL] [Abstract][Full Text] [Related]
8. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway. Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of long non-coding RNA RP11-708H21.4 is associated with poor prognosis for colorectal cancer and promotes tumorigenesis through regulating AKT/mTOR pathway. Sun L; Jiang C; Xu C; Xue H; Zhou H; Gu L; Liu Y; Xu Q Oncotarget; 2017 Apr; 8(17):27929-27942. PubMed ID: 28427191 [TBL] [Abstract][Full Text] [Related]
10. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways. Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405 [TBL] [Abstract][Full Text] [Related]
12. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway. Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539 [TBL] [Abstract][Full Text] [Related]
13. Activin a Receptor Type 2A Mutation Affects the Tumor Biology of Microsatellite Instability-High Gastric Cancer. Yuza K; Nagahashi M; Ichikawa H; Hanyu T; Nakajima M; Shimada Y; Ishikawa T; Sakata J; Takeuchi S; Okuda S; Matsuda Y; Abe M; Sakimura K; Takabe K; Wakai T J Gastrointest Surg; 2021 Sep; 25(9):2231-2241. PubMed ID: 33420656 [TBL] [Abstract][Full Text] [Related]
14. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation. Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935 [TBL] [Abstract][Full Text] [Related]
15. Microsatellite Instability-Related Zhao L; Zhang J; Qu X; Yang Y; Gong Z; Yang Y; Wu Z; Guo W Onco Targets Ther; 2020; 13():3809-3821. PubMed ID: 32440149 [TBL] [Abstract][Full Text] [Related]
16. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway. Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562 [TBL] [Abstract][Full Text] [Related]
17. Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR/MSI-H gastric adenocarcinoma. Wang Z; Wang X; Xu Y; Li J; Zhang X; Peng Z; Hu Y; Zhao X; Dong K; Zhang B; Gao C; Zhao X; Chen H; Cai J; Bai Y; Sun Y; Shen L BMC Med; 2022 Apr; 20(1):133. PubMed ID: 35443723 [TBL] [Abstract][Full Text] [Related]
18. TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status. Agarwal S; Behring M; Kim HG; Chandrashekar DS; Chakravarthi BVSK; Gupta N; Bajpai P; Elkholy A; Al Diffalha S; Datta PK; Heslin MJ; Varambally S; Manne U Mol Oncol; 2020 Dec; 14(12):3007-3029. PubMed ID: 33037736 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers. Liu F; Zhong F; Wu H; Che K; Shi J; Wu N; Fu Y; Wang Y; Hu J; Qian X; Fan X; Wang W; Wei J Oncologist; 2023 Mar; 28(3):e136-e144. PubMed ID: 36724040 [TBL] [Abstract][Full Text] [Related]
20. CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis. Xu H; Liu Y; Cheng P; Wang C; Liu Y; Zhou W; Xu Y; Ji G J Exp Clin Cancer Res; 2020 Dec; 39(1):283. PubMed ID: 33317596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]